or Try an Advanced Search...

    Non Small Cell Lung Cancer Stocks List

    Symbol Grade Name % Change
    LCTX F Lineage Cell Therapeutics, Inc. 7.55
    NXTC D NextCure, Inc. 4.96
    GNLX F Genelux Corporation 4.18
    HCM B Hutchison China MediTech Limited 2.45
    AGEN D Agenus Inc. 1.61
    OPK C OPKO Health Inc. 1.54
    NVCR D NovoCure Limited 1.22
    EVAX D Evaxion Biotech A/S 1.01
    ACHV B Achieve Life Sciences, Inc. 0.95
    LYEL C Lyell Immunopharma, Inc. 0.85
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
    Related Stock Lists: Cancer Small Cell Lung Cancer Clinical Medicine Medicine Biotechnology Immunotherapy Biopharmaceutical Ovarian Cancer Pancreatic Cancer Alzheimer's Disease Biology Cancer Vaccine Clinical Trial Experimental Cancer Treatments Immunotherapies Infectious Diseases Life Sciences Melanoma Oncolytics Biotech Prostate Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Non Small Cell Lung Cancer stocks.

    Symbol Grade Name Weight
    CNCR D Loncar Cancer Immunotherapy ETF 4.77
    FBT D First Trust Amex Biotech Index Fund 3.28
    GERM C ETFMG Treatments Testing and Advancements ETF 2.44
    IBB C iShares Nasdaq Biotechnology Index Fund 1.83
    XHS C SPDR S&P Health Care Services ETF 1.36
    View all Non Small Cell Lung Cancer ETFs...
    Compare ETFs
    Compare CNCR to FBT Compare CNCR to IBB Compare FBT to IBB

        Non Small Cell Lung Cancer Stocks Recent News

        Date Stock Title
        May 3 NVCR NovoCure Limited Q1 Earnings: Core Business Accelerating
        May 3 NVCR NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript
        May 3 OPK OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024
        May 3 NVCR NovoCure (NVCR) Q1 2024 Earnings Call Transcript
        May 2 NXTC NextCure GAAP EPS of -$0.61 misses by $0.15
        May 2 NXTC NextCure Provides Business Update and Reports First Quarter 2024 Financial Results
        May 2 NVCR NovoCure Limited (NVCR) Q1 2024 Earnings Call Transcript
        May 2 NVCR NovoCure Limited 2024 Q1 - Results - Earnings Call Presentation
        May 2 NVCR NovoCure Ltd (NVCR) Q1 2024 Earnings: Revenue Surpasses Estimates, Narrower Net Loss Reported
        May 2 NVCR NovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates
        May 2 NVCR Novocure secures new $400M multi-tranche debt financing, shares up
        May 2 NVCR NovoCure GAAP EPS of -$0.36 beats by $0.06, revenue of $138.5M beats by $7.05M
        May 2 NVCR Novocure Secures New $400 Million Multi-Tranche Non-Dilutive Debt Financing from Pharmakon
        May 2 NVCR Novocure Reports First Quarter 2024 Financial Results
        May 1 NVCR NovoCure Q1 2024 Earnings Preview
        May 1 AGEN Agenus regains compliance with Nasdaq minimum bid price requirement
        May 1 AGEN Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement
        Apr 30 AGEN Time Is Running Out For Agenus To Raise Cash
        Apr 30 LCTX Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM)
        Apr 29 LCTX Lineage Cell Therapeutics board chairman passes away
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Instruments & Supplies
        Related Stock Lists: Cancer Biotechnology Clinical Medicine Medicine Small Cell Lung Cancer Immunotherapy Immunotherapies Ovarian Cancer Pancreatic Cancer Solid Tumors Advanced Cancer Biology Biopharmaceutical Clinical Trial Life Sciences Stem Cell Treatment Of Ovarian Cancer Tumor Virotherapy Active Pharmaceutical Ingredients
        Non Small Cell Lung Cancer

        Non-Small Cell Lung Cancer (NSCLC) is the most common type of lung cancer, accounting for about 85% of all cases. It is a type of cancer that begins in the cells that line the airways of the lungs. NSCLC is divided into three main subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Symptoms of NSCLC include a persistent cough, chest pain, shortness of breath, and coughing up blood. Treatment options for NSCLC include surgery, chemotherapy, radiation therapy, and targeted therapy.

        Browse All Tags